EUVIMEDDescoperă EUVIMED
Crossref

Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer

Minyue Du, Lan Wang, Shuo Han, Can Huang

Research · 2026 · 1 (1)

DOI: 10.65613/739880 ↗

At a glance

Journal article in Research, 2026. Written by Minyue Du and 3 co-authors.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Cite

APA

Du, M., Wang, L., Han, S., & Huang, C. (2026). Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer. Research, 1(1). https://doi.org/10.65613/739880

Vancouver

Du M, Wang L, Han S, Huang C. Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer. Research. 2026;1(1). doi:10.65613/739880

BibTeX
@article{Du2026,
  author = {Du, Minyue and Wang, Lan and Han, Shuo and Huang, Can},
  title = {Androgen Receptor Expression-Guided Optimization of Neoadjuvant Therapy and Prognostic Modeling in HER2-Low Triple-Negative Breast Cancer},
  journal = {Research},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.65613/739880}
}
Start for free →